Biotech Stock News: (GALE) (AMGN) (ARIA) (BXLT)

Galena Biopharma (NASDAQ:GALE) On Monday August 24, 2015 Shares of Galena Biopharma were able to close the day up 11% after announcing an update for its phase 3 trial known as the “PRESENT” trial. The company announced that the independent data monitoring committee — IDMC — concluded that it would be able to reduce the … Read more

Ariad Pharmaceuticals (ARIA) Stock Declines Slightly After Earnings

Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) Ariad Pharmaceuticals is down slightly today following the release of their first quarter earnings report. So, we’ll look into the report to figure out why the stock is falling, talk about what the company does, and discuss what we can expect to see from the stock moving forward. ARIA Misses … Read more

Ariad Pharmaceuticals (ARIA) Stock Climbs | CEO To Retire

Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) Ariad Pharmaceuticals stock is up today on high volume. However, it’s not unfounded growth as there’s a reason for all the madness. Today, ARIA’s CEO announced that he would retire as part of a settlement. So, we’ll talk about who pushed the CEO out of the chair, who will be … Read more

Ariad (ARIA) Stock | Will It Continue To Climb?

Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) Ariad Pharmaceuticals stock climbed yesterday following the company’s announcement of preclinical data from 2 studies at the American Association for Cancer Research Annual Meeting 2015. The data was provided through two different presentations… ARIA Preclinical Data Presentations Oral Presentation on Brigatnib Discovery This demonstration described the design and chemical structure … Read more

Today’s Top Movers In The Market

As always, today was an exciting day in the market. Here’s a list of the top moving stocks by industry today… Tech’s Biggest Moving Stocks Tech’s Fastest Growing Stocks Today Apple (AAPL) – Apple stocks closed the day off at $124.25 per share after a gain of $1.36 or 1.10%. MicroVision (MVIS) – MicroVision stocks … Read more

Biotech News 2/16/15 to 2/20/15

Oncolytics Biotech (ONCY) Shares of Oncolytics gained about 36% on 2/17/15 when it had announced that the company received FDA Orphan Drug Designation status for its pancreatic cancer drug Reolysin. Reolysin is a variant of the ReoVirus which occurs naturally in the environment. Oncolytics has engineered Reolysin to multiply at an alarming rate inside of … Read more